Hormonal and metabolic effects of radiotherapy in acromegaly: Long-term results in 128 patients followed in a single center

Journal of Clinical Endocrinology and Metabolism

Volumn 85, Issue 10, 2000, Pages 3779-3785

  Barrande, Gaëlle ^a   Pittino Lungo, Myriam ^a   Coste, Joël ^a   Ponvert, Dominique ^b   Bertagna, Xavier ^a   Luton, Jean Pierre ^a   Bertherat, Jérôme ^a  

^a Hôpital Cochin ^*  (France)

^b INSTITUT CURIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C;

ACROMEGALY; ADULT; ARTICLE; DIABETES MELLITUS; FEMALE; FOLLOW UP; GLUCOSE INTOLERANCE; GROWTH HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

EID: 0033756532     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.85.10.6870     Document Type: Article

References (42)

1. Results of transsphenoidal microsurgery for growth hormone-secreting pituitary adenoma in a series of 214 patients
2. Transsphenoidal adenomectomy for growth hormone-secreting pituitary adenomas in acromegaly: Outcome analysis and determinants of failure
3. Outcome of transsphenoidal surgery for acromegaly using strict criteria for surgical cure
4. Transsphenoidal microsurgery for growth hormone-secreting pituitary adenomas: Initial outcome and long-term results
5. Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly
6. Outcome of transphenoidal surgery for acromegaly and its relationship to surgical experience
7. Epidemiology and long-term survival in acromegaly
8. An audit of outcome of treatment in acromegaly
9. Determinants of clinical outcome and survival in acromegaly
10. Mortality and cancer incidence in acromegaly: A retrospective cohort study
11. Mortality in acromegaly
12. How effective is external pituitary irradiation for growth hormone secreting pituitary tumours?
13. Radiation therapy of acromegaly
14. Treatment of secretory pituitary adenoma with radiation therapy
15. Low-dose pituitary irradiation for acromegaly
16. Megavoltage pituitary irradiation lowers but seldom leads to safe GH levels in acromegaly: A long-term follow-up study
17. Pituitary irradiation is ineffective in normalizing plasma insulin-like growth factor I in patients with acromegaly
18. Pituitary
19. Current treatment guidelines for acromegaly
20. Application of the method of separation by talc to the radioimmunologic determination of somatotropic hormone
21. The importance of insulin-like growth factor (somatomedin) measurements in the diagnosis and surveillance of acromegaly
22. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance
23. Random-effects models for longitudinal data
24. Predictive value of statistical models
25. Conventional supervoltage irradiation is an effective treatment for acromegaly
26. Persistent or recurrent acromegaly
27. Long-term effects of radiotherapy for acromegaly
28. Role of radiation therapy in clinical hormonally-active pituitary adenomas
29. Results of radiotherapy in the treatment of acromegaly: Lack of ophthalmologic complications
30. Factors determining the long-term outcome of surgery for acromegaly
31. Outpatient assessment of residual growth hormone secretion in treated acromegaly with overnight urinary growth hormone excretion, random serum growth hormone and insulin like growth factor-1
32. A comparison of different methods for diagnosing acromegaly
33. Growth hormone responses to oral glucose loading measured by highly sensitive enzyme immunoassay in normal subjects and patients with glucose intolerance and acromegaly
34. Evaluation of disease status with sensitive measures of growth hormone secretion in 60 postoperative patients with acromegaly
35. Acromegaly
36. Acromegaly: Clinical and biochemical features in 500 patients
37. Hypopituitarism following radiation therapy of pituitary adenomas
38. Radiotherapy for pituitary adenoma: Long-term outcome and sequelae
39. Persistent or recurrent acromegaly. Long-term endocrinologic efficacy and neurologic safety of postsurgical radiation therapy
40. The role of radiotherapy in acromegaly
41. Acromegaly